- E16.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM E16.4 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E16.4 – other international versions of ICD-10 E16.4 may differ.
ICD-10-CM E16.4 is grouped within Diagnostic Related Group(s):
- 380 Complicated peptic ulcer with mcc
- 381 Complicated peptic ulcer with cc
- 382 Complicated peptic ulcer without cc/mcc
Applicable To
- Hypergastrinemia
- Hyperplasia of pancreatic endocrine cells with gastrin excess
- Zollinger-Ellison syndrome
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E16.4:
- gastrin secretion > Abnormal, abnormality, abnormalities
- secretion > Abnormal, abnormality, abnormalities
- gastrin > secretion E16.4
- with excess > alpha E16.8
- gastrin > with excess E16.4
- gastrin > Hypersecretion
- secretion > Increase, increased
- gastrin > secretion E16.4